Assessing and Treating Forgetfulness and Cognitive Problems in Adults With HIV

Journal of the Association of Nurses in AIDS Care

Volumn 24, Issue SUPPL. 1, 2013, Pages

  Vance, David E ^a   Fazeli, Pariya L ^b   Moneyham, Linda ^a   Keltner, Norman L ^a   Raper, James L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Cognitive remediation; Comorbidity; Forgetfulness; HIV; Speed of processing

Indexed keywords

ADULT; ARTICLE; COGNITIVE DEFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MEMORY DISORDER; PSYCHOLOGICAL ASPECT;

ADULT; COGNITION DISORDERS; HIV INFECTIONS; HUMANS; INCIDENCE; MEMORY DISORDERS;

EID: 84871753409     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2012.03.006     Document Type: Article

References (89)

1. Al-Khindi T., Zakzanis K.K., van Gorp W.G. Does antiretroviral therapy improve HIV-associated cognitive impairment? A quantitative review of the literature. Journal of the International Neuropsychological Society 2011, 17:1-14. 10.1017/S1355617711000968.
2. Athilingam P., King K.B., Burgin S.W., Ackerman M., Cushman L.A., Chen L. Montreal Cognitive Assessment and Mini-Mental Status Examination compared as cognitive screening tools in heart failure. Heart and Lung: The Journal of Acute and Critical Care 2011, 40(6):521-529. 10.1016/j.hrtlng.2010.11.002.
3. Atkins J.H., Rubenstein S.L., Sota T.L., Rueda S., Fenta H., Bacon J., Rourke S.B. Impact of social support on cognitive symptom burden in HIV/AIDS. AIDS Care 2010, 22(7):793-802. 10.1080/09540120903482994.
4. Baldewicz T.T., Leserman J., Silva S.G., Petitto J.M., Golden R.N., Perkins D.O., Evans D.L., et al. Changes in neuropsychological functioning with progression of HIV-1 infection: Results of an 8-year longitudinal investigation. AIDS and Behavior 2004, 8(3):345-355. 10.1023/B:AIBE.0000044081.42034.54.
5. Bassil N., Morley J.E. Late-life onset hypogonadism: A review. Clinics in Geriatric Medicine 2010, 26(2):197-222. 10.1016/j.cger.2010.02.003.
6. Basso M.R., Bornstein R.A. Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months. Journal of Clinical & Experimental Neuropsychology 2000, 22(2):208-218. 10.1076/1380-3395.
7. Becker B.W., Thames A.D., Woo E., Castellon S.A., Hinkin C.A. Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behavior 2011, 15(8):1888-1894. 10.1007/s10461-011-9924-z.
8. Berger J.R., Kumar M., Kumar A., Fernandez J.B., Levin B. Cerebrospinal fluid dopamine in HIV-1 infection. AIDS 1994, 8(1):67-71.
9. Bornstein R.A., Nasrallah H.A., Para M.F., Whitacre C.C., Rosenberger P., Fass R.J. Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS 1993, 7(4):519-524. 10.1097/00002030-199304000-00011.
10. Brinkley T.E., Lovato J.F., Arnold A.M., Furberg C.D., Kuller L.H., Burke G.L., Williamson J.D., et al. Effect of ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women. American Journal of Hypertension 2010, 23(5):528-533. 10.1038/ajh.2010.14.
11. Broadbent D.E., Cooper P.F., FitzGerald P., Parkes K.R. The Cognitive Failures Questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology 1982, 21(1):1-16.
12. Bruehl H., Wolf O.T., Sweat V., Tirsi A., Richardson S., Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Research 2009, 1280:186-194. 10.1016/j.brainres.2009.05.032.
13. Charach G., Kaysar N., Grosskopf I., Rabinovich A., Weintraub M. Methylphenidate has positive hypocholesterolemic and hypotrigylceridemic effects: New data. Journal of Clinical Pharmacology 2009, 49(7):848-851. 10.1177/0091270009336736.
14. Choi H.H., Gray P.B., Storer T.W., Calof O.M., Woodhouse L., Singh A.B., Bhasin S., et al. Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss. Journal of Clinical Endocrinology & Metabolism 2005, 90(3):1531-1541. 10.1210/jc.2004-1677.
15. Ciccarelli N., Fabbiani M., Di Giambenedetto S., Fanti I., Baldonero E., Bracciale L., Silveri M.C., et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology 2011, 76(16):1403-1409. 10.1212/WNL.0b013e31821670fb.
16. Claypoole K.H., Elliott A.J., Uldall K.K., Russo J., Dugbartey A.T., Bergam K., Roy-Byrne P.P. Cognitive functions and complaints in HIV-1 individuals treated for depression. Applied Neuropsychology 1998, 5(2):74-84. 10.1207/s15324826an0502_3.
17. Crawford J.R., Smith G., Maylor E.A., Sala S.D., Logie R.H. The Prospective and Retrospective Memory Questionnaire (PRMQ): Normative data and latent structure in a large non-clinical sample. Memory 2003, 11(3):261-275. 10.1080/09658210244000027.
18. Cumming T.B., Bernhardt J., Linden T. The Montreal Cognitive Assessment: Short cognitive evaluation in a large stroke trial. Stroke 2011, 42:2642-2644. 10.1161/STROKEAHA.111.619486.
19. Dou H., Grotepas C.B., McMillan J.M., Destache C.J., Chaubal M., Werling J., Gendelman H.E., et al. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. Journal of Immunology 2009, 183(1):661-669. 10.4049/jimmunol.0900274.
20. Eggert D., Dash P.K., Gorantla S., Dou H., Schifitto G., Maggirwar S.B., Gendelman H.E., et al. Neuroprotective activities of CEP-1347 in models of neuroAIDS. Journal of Immunology 2010, 184(2):746-756. 10.4049/jimmunol.0902962.
21. Fields R.D. The other brain 2009, Simon & Schuster, New York, NY.
22. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12(3):189-198.
23. Foster P.P., Rosenblatt K.P., KuljiŠ R.O. Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease. Frontiers in Neurology 2011, 2(28):1-15. 10.3389/fneur.2011.00028.
24. Gibbs R.B. Does short-term estrogen therapy produce lasting benefits to the brain?. Endocrinology 2010, 151(3):843-845. 10.1210/en.2009-1453.
25. Gorby H.E., Brownawell A.M., Falk M.C. Do specific dietary constituents and supplements affect mental energy? Review of the evidence. Nutrition Reviews 2010, 68(12):697-718. 10.1111/j.1753-4887.2010.00340.x.
26. Hardy D., Vance D. The neuropsychology of HIV/AIDS in older adults. Neuropsychology Review 2009, 19(2):263-272. 10.1007/s11065-009-9087-0.
27. Harel Y., Appleboim N., Lavie M., Achiron A. Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process. Journal of Neurological Science 2009, 276(1-2):38-40. 10.1016/j.jns.2008.08.025.
28. Harezlak J., Buchthal S., Taylor M., Schifitto G., Zhong J., Darr E., Navia B., et al. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral therapy. AIDS 2011, 25(5):625-633. 10.1097/QAD.0b013e3283427da7.
29. Harzke A.J., Williams M.L., Nilsson-Schonnesson L., Ross M.W., Timpson S., Keel K.B. Psychosocial factors associated with adherence to antiretroviral medications in a sample of HIV-positive African American drug users. AIDS Care 2004, 16(4):458-470. 10.1080/09540120410001683394.
30. Heaton R.K., Clifford D.B., Franklin D.R., Woods S.P., Ake C., Vaida F., Grant I., et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy (CHARTER Study). American Academy of Neurology 2010, 75:2087-2096. 10.1212/WNL.0b013e318200d727.
31. Hinkin C.H., Castellon S.A., Hardy D.J., Farinpour R., Newton T., Singer E. Methylphenidate improves HIV-1-associated cognitive slowing. Journal of Neuropsychiatry & Clinical Neuroscience 2001, 113(2):248-254. 10.1176/appi.neuropsych.13.2.248.
32. Hogervorst E., Bandelow S. Sex steroids to maintain cognitive function in women after the menopause: A meta-analyses of treatment trials. Maturitas 2010, 66(1):56-71.
33. Howard A.A., Arnsten J.H., Lo Y., Vlahov D., Rich J.D., Schuman P., Schoenbaum E.E., et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 2002, 16:2175-2182. 10.1097/00002030-200211080-00010.
34. Iudicello J.E., Woods S.P., Vigil O., Scott J.C., Cherner M., Heaton R.K., Grant I., et al. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. Journal of Clinical & Experimental Neuropsychology 2010, 32(7):704-718. 10.1080/13803390903512637.
35. Janicki S.C., Schupf N. Hormonal influences on cognition and risk for Alzheimer's disease. Current Neurology and Neuroscience Reports 2010, 10:359-366. 10.1007/s11910-010-0122-6.
36. Julien R.M. A primer of drug action 1998, W. H. Freeman and Company, New York, NY.
37. Kirk J.B., Goetz M.B. Human immunodeficiency virus in an aging population, a complication of success. Journal of the American Geriatrics Society 2009, 57(11):2129-2138. 10.1111/j.1532-5415.2009.02494.x.
38. Koopmans P.P., Ellis R., Best B.M., Letendre S. Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration?. The Netherlands Journal of Medicine 2009, 67(6):206-211.
39. Koski L., Brouillette M.-J., Lalonde R., Hello B., Wong E., Tsuchida A., Fellows L.K. Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment. HIV Medicine 2011, 12:472-480. 10.1111/j.1468-1293.2010.00910.x.
40. Leblanc E., Chan B., Nelson H.D. Hormone replacement therapy and cognition. U. S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews 2002, Agency for Healthcare Research and Quality, Rockville, MD.
41. Leistner E., Drewke C. Ginkgo biloba and ginkgotoxin. Journal of Natural Products 2010, 73:86-92. 10.1021/np9005019.
42. Lentz M.R., Kim W.K., Kim H., Soulas C., Lee V., Venna N., González R.G., et al. Alterations in brain metabolism during the first year of HIV infection. Journal of Neurovirology 2011, 17(3):220-229. 10.1007/s13365-011-0030-9.
43. Leserman J., Barroso J., Pence B., Salahuddin N., Harmon J. Trauma, stressful life events and depression predict HIV-related fatigue. AIDS Care 2008, 20:1258-1265. 10.1080/09540120801919410.
44. Letendre S., Marquie-Beck J., Caparelli E., Best B., Clifford D., Collier A.C., Ellis R.J., et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the center nervous system. Archives of Neurology 2008, 65(1):65-70. 10.1001/archneurol.2007.31.
45. Letendre S., Woods S.P., Ellis R.J., Atkinson J.H., Masliah E., van den Brande G., et al. Lithium improves HIV-associated neurocognitive impairment. AIDS 2006, 20(14):1885-1888. HNRC Group. 10.1097/01.aids.0000244208.49123.1b.
46. Lindl K.A., Marks D.A., Kolson D.L., Jordan-Sciutto K.L. HIV-associated neurocognitive disorder: Pathogenesis and therapeutic opportunities. Journal of Neuroimmune Pharmacology 2010, 5:294-309. 10.1007/s11481-010-9205-z.
47. Malaspina L., Woods S.P., Moore D.J., Depp C., Letendre S.L., Jeste D., Grant I. Successful cognitive aging in persons living with HIV infection. Journal of Neurovirology 2011, 17:110-119. 10.1007/s13365-010-0008-z.
48. Mar Fan H.G., Clemons M., Xu W., Chemerynsky I., Breunis H., Braganza S., Tannock I.F. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 2008, 16(6):577-583. 10.1007/s00520-007-0341-9.
49. Marcotte T.D., Heaton R.K., Wolfson T., Taylor M.J., Alhassoon O., Arfaa K., Grant I. The impact of HIV-related neuropsychological dysfunction on driving behavior. Journal of the International Neuropsychological Society 1999, 5:579-592. 10.1017/S1355617799577011.
50. McCombe J.A., Auer R.N., Maingat F.G., Houston S., Gill M.J., Power C. Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: Outcomes and epidemiology. Neurology 2009, 72(9):835-841. 10.1212/01.wnl.0000343854.80344.69.
51. McElhiney M., Rabkin J., van Gorp W., Rabkin R. Modafinil effects on cognitive function in HIV+ patients treated for fatigue: A placebo controlled study. Journal of Clinical and Experimental Neuropsychology 2010, 32(5):474-480. 10.1080/13803390903201769.
52. Mitsiades N., Correa D., Gross C.P., Hurria A., Slovin S.F. Cognitive effects of hormonal therapy in older adults. Seminars in Oncology 2008, 35(6):569-581. 10.1053/j.seminoncol.2008.08.2002.
53. Nasreddine, Z. (2010). Montreal Cognitive Assessment (MoCA): Administration and scoring instructions. Retrieved from http://www.mocatest.org.
54. Neundorfer M.M., Camp C.J., Lee M.M., Skrajner M.J., Malone M.L., Carr J.R. Compensating for cognitive deficits in persons aged 50 and over with HIV/AIDS: A pilot study of a cognitive intervention. Journal of HIV/AIDS & Social Services 2004, 3(1):79-98. 10.1300/J187v03n01_07.
55. Parsons T.D., Braaten A.J., Hall C.D., Robertson K.R. Better quality of life with neuropsychological improvement on HAART. Health and Quality of Life Outcomes 2006, 4:11. 10.1186/1477-7525-4-11.
56. Raper J.L. The medical management of HIV disease. The person with HIV/AIDS: Nursing perspective (4th ed.; pp. 221-291) 2010, Springer Publishing Company, New York, NY. J.D. Durham, F.R. Lashley (Eds.).
57. Reger M., Welsch R., Razani J., Martin D.J., Boone K.B. A meta-analysis of the neuropsychological sequelae of HIV infection. Journal of the International Neuropsychological Society 2002, 8(3):410-424. 10.1017/S1355617702813212.
58. Rrapo E., Zhu Y., Tian J., Hou H., Smith A., Fernandez F., Giunta B., et al. Green tea-EGCG reduces GFAP associated neuronal loss in HIV-1 tat transgenic mice. American Journal of Translational Research 2009, 1(1):72-79.
59. Schifitto G., Navia B.A., Yiannoutsos C.T., Marra C.M., Chang L., Ernst T., Lipton S.A., et al. Memantine and HIV-associated cognitive impairment: A neuropsychological and proton magnetic resonance spectroscopy study. AIDS 2007, 21(14):1877-1886. 10.1097/QAD.0b013e32813384e8.
60. Schweinsburg B.C., Taylor M.J., Alhassoon O.M., Gonzalez R., Brown G.G., Ellis R.J., Grant I., et al. Brain mitochondrial injury in human immunodeficiency virus-seropositive individuals taking nucleoside reverse transcriptase inhibitors. Journal of Neurovirology 2005, 11:356-364. 10.1080/13550280591002342.
61. Serby M.J., Burns S.J., Roane D.M. Treatment of memory loss with herbal remedies. Current Treatment Options in Neurology 2011, 13(5):520-528. 10.1007/s11940-011-0135-8.
62. Serby M.J., Yhap C., Landron E.Y. A study of herbal remedies for memory complaints. Journal of Clinical Neuropsychiatry and Clinical Neuroscience 2010, 22(3):345-347. 10.1176/appi/neuropsych.22.3.345.
63. Sharma B., Singh N., Singh M., Jaggi A.S. Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia. Pharmacology, Biochemistry and Behavior 2008, 89:535-545. 10.1016/j.pbb.2008.02.012.
64. Sharma V., Perros P. The management of hypogonadism in aging male patients. Postgraduate Medicine 2009, 121(1):113-121. 10.3810/pgm.2009.01.1960.
65. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Wactawski-Wende J., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association 2003, 289:2651-2662. 10.1001/jama.289.20.2651.
66. Simioni S., Cavassini M., Annoni J.M., Abraham A.R., Bourquin I., Schiffer V., Du Pasquier R.A., et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 2010, 24:1243-1250. 10.1097/QAD.0b013e3283354a7b.
67. Snitz B.E., O'Meara E.S., Carlson M.C., Arnold A.M., Ives D.G., Rapp S.R., DeKosky S.T., et al. Ginkgo biloba for preventing cognitive decline in older adults: A randomized trial. Journal of the American Medical Association 2009, 302(24):2663-2670. 10.1001/jama.2009.1913.
68. Sweet L., Van Adel M., Metcalf V., Wright L., Harley A., Leiva R., Taler V. The Montreal Cognitive Assessment (MoCA) in geriatric rehabilitation: Psychometric properties and association with rehabilitation. International Psychogeriatrics 2011, 23(10):1582-1591. 10.1017/S1041610211001451.
69. Thames A.D., Becker B.W., Marcotte T.D., Hines L.J., Foley J.M., Ramezani A., Hinkin C.H., et al. Depression, cognition, and self-appraisal of functional abilities in HIV: An examination of subjective appraisal versus objective performance. Clinical Neuropsychology 2011, 25(2):224-243. 10.1080/13854046.2010.539577.
70. Thompson P.M., Dutton R.A., Hayashi K.M., Toga A.W., Lopez O.L., Aizenstein H.J., Becker J.T. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proceedings of the National Academy of Science 2005, 102(43):15647-15652. 10.1073/pnas.0502548102.
71. Toglia J., Fitzgerald K.A., O'Dell M.W., Mastrogiovanni A.R., Lin C.D. The Mini-Mental State Examination and Montreal Cognitive Assessment in persons with mild subacute stroke: Relationship to functional outcome. Archives of Physical and Medical Rehabilitation 2011, 92:792-798. 10.1016/j.apmr.2010.12.034.
72. Tomasi D., Volkow N.D., Wang G.J., Wang R., Telang F., Caparelli E.C., Fowler J.S., et al. Methylphenidate enhances brain activation response to visual attention and working memory tasks in health controls. Neuroimage 2011, 54:3101-3110. 10.1016/j.neuroimage.2010.10.060.
73. Turner D.C., Clark L., Dowson J., Robbins T.W., Sahakian B.J. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biological Psychiatry 2004, 55(10):1031-1040. 10.1016/j.biopsych.2004.02.008.
74. Valcour V., Yee P., Williams A.E., Shiramizu B., Watters M., Selenes O., Sacktor N., et al. Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection - The Hawaii Aging with HIV Cohort. Journal of Neurovirology 2006, 12(5):387-391. 10.1080/13550280600915339.
75. van Dyck C.H., McMahon T.J., Rosen M.I., O'Malley S.S., O'Connor P.G., Lin C.H., Kosten T.R., et al. Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: A pilot study. Journal of Neuropsychiatry and Clinical Neuroscience 1997, 9:29-36.
76. Vance D.E., Dawson J., Wadley V.G., Edwards J.D., Roenker D.L., Rizzo M., Ball K.K. The Accelerate Study: The longitudinal effect of speed of processing training on cognitive performance of older adults. Rehabilitation Psychology 2007, 51(1):89-96. 10.1037/0090-5550.52.1.89.
77. Vance D.E., Eagerton G., Harnish B., McKie-Bell P., Fazeli P. Cognitive prescription across the lifespan: A nursing approach to increasing cognitive reserve. Journal of Gerontological Nursing 2011, 37(4):22-29. 10.3928/00989134-20101202-03.
78. Vance D.E., Farr K., Struzick T.C. Assessing the clinical value of cognitive appraisal in adults aging with HIV. Journal of Gerontological Nursing 2008, 34(1):36-41. 10.3928/00989134-20080101-11.
79. Vance D.E., Fazeli P.L., Ross L., Wadley V.G., Ball K.K. Speed of processing training with middle-aged and older adults with HIV: A pilot study. Journal of the Association of Nurses in AIDS Care 2012, 23(6):500-510. 10.1016/j.jana.2012.01.005.
80. Vance D.E., Graham M.A., Fazeli P.L., Heaton K., Moneyham L. An overview of non-pathological geroneuropsychology: Implications for nursing practice and research. Journal of Neuroscience Nursing 2012, 44(1):43-53. 10.1097/JNN.0b013e31823ae48b.
81. Vance D.E., Larsen K.I., Eagerton G., Wright M.A. Comorbidities and cognitive functioning: Implications for nursing practice and research. Journal of Neuroscience Nursing 2011, 43(4):215-224. 10.1097/JNN.0b013e3182212a04.
82. Vance D.E., Mugavero M., Willig J., Raper J.L., Saag M.S. Aging with HIV: A cross-sectional study of co-morbidity prevalence and clinical characteristics across decades of life. Journal of the Association of Nurses in AIDS Care 2011, 22(1):17-25. 10.1016/j.jana.2010.04.003.
83. Vance D.E., Ross L.A., Downs C.A. Self-reported cognitive ability and global cognitive performance in adults with HIV. Journal of Neuroscience Nursing 2008, 40(1):6-13. 10.1097/01376517-200802000-00003.
84. Vance D.E., Struzick T.C., Farr K. Spaced retrieval technique - A cognitive tool for social workers and their clients. Journal of Gerontological Social Work 2010, 52(2):148-158. 10.1080/01634370903409745.
85. Vance D.E., Webb N., Marceaux J., Viamonte S., Foote A., Ball K.K. Mental stimulation, neural plasticity, and aging: Directions for nursing practice and research. Journal of Neuroscience Nursing 2008, 40(4):241-249. 10.1097/01376517-200808000-00008.
86. Volkow N., Swanson J. The action of enhancers can lead to addiction. Nature 2008, 451:520. 10.1038/451520a.
87. 1 receptors in the prefrontal cortex. Nature 1995, 376:572-575. 10.1038/376572a0.
88. Woods S.P., Carey C.L., Morgan L.M., Dawson M.S., Letendre S.L., Grant I. Frequency and predictors of self-reported prospective memory complaints in individuals with HIV. Archives of Clinical Neuropsychology 2007, 22:187-195. 10.1016/j.acn.2006.12.006.
89. Yesavage J.A., Friedman L., Ashford J.W., Kraemer H.C., Mumenthaler M.S., Noda A., Hoblyn J. Acetylcholinesterase inhibitor in combination with cognitive training in older adults. Journal of Gerontology: Psychological Science 2008, 63(5):P288-P294.